CTLA4 and cutaneous mastocytosis: Based on the results of risk analyses, clinical aspects of patients, biological aspects of the tumor, and survival of CM patients, we selected CTLA-4 c.-1577G>A as the SNV of greatest interest for this study, thus making it the object of functional analyses.